R.L. Siegel, K.D. Miller, J. Ahmedin, Cancer statistics, 2015. Ca A Cancer Journal for Clinicians 60(5), 277–300 (2010)

PubMed  Google Scholar 

Y.N.S. Wong et al., Evolution of androgen receptor targeted therapy for advanced prostate cancer. Nat. Reviews Clin. Oncol. 11(6), 365–376 (2014)

Article  CAS  Google Scholar 

A. Mathur et al., Subverting ER-stress towards apoptosis by nelfinavir and curcumin coexposure augments docetaxel efficacy in castration resistant prostate cancer cells. Plos One 9(8), e103109 (2014)

Article  Google Scholar 

A. Katzenwadel, P. Wolf, Androgen deprivation of prostate cancer: leading to a therapeutic dead end. Cancer Lett 367(1), 12–17 (2015)

Article  CAS  PubMed  Google Scholar 

D.A. Gewirtz, S.E. Holt, L.W. Elmore, Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem. Pharmacol 76(8), 947–957 (2008)

Article  CAS  PubMed  Google Scholar 

A.V. D’Amico et al., Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. Jama 2008(3), 289–295 (2008)

Google Scholar 

M.D. Mason et al., Final report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus androgen-deprivation therapy alone in locally advanced prostate Cancer. J. Clin. Oncol 33(19), 2143–2150 (2015)

Article  PubMed  PubMed Central  Google Scholar 

C. Lin et al., Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 139(6), 1069–1083 (2009)

Article  Google Scholar 

M.J. Schiewer et al., Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov 2(12), 1134 (2012)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Asim et al., Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer. Nat. Commun. 8(1), 374 (2017)

D. D'Amours et al., Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 342, 249-268 (1999)

 O. Huambachano et al., Double-stranded DNA binding domain of poly(ADP-ribose) polymerase-1 and molecular insight into the regulation of its activity. J. Biol. Chem 286(9), 7149 (2011)

Article  Google Scholar 

J.P. Gagné et al., Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes. Nucleic Acids Res. 36(22), 6959–6976 (2008)

Article  Google Scholar 

S. Jungmichel et al., Proteome-wide identification of poly(ADP-Ribosyl)ation targets in different genotoxic stress responses. Mol. Cell 52(2), 272–285 (2013)

Article  CAS  PubMed  Google Scholar 

C.J. Lord, A.N.J. Tutt, A. Ashworth, Synthetic lethality and Cancer therapy: Lessons learned from the development of PARP inhibitors. Annu. Rev. Med 66(1), 455–470 (2015)

Article  CAS  PubMed  Google Scholar 

J.M. Rodríguez-Vargas, F.J. Oliver-Pozo, F. Dantzer, PARP1 and Poly(ADP-ribosyl)ation signaling during autophagy in response to nutrient deprivation. Oxid. Med. Cell. Longev., 2641712 (2019)

T. Ogura et al., Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells. Int. J. Oncol 48(6), 2330–2338 (2016)

Article  CAS  PubMed  PubMed Central  Google Scholar 

U. Igor, D.P. Bartel, lincRNAs: genomics, evolution, and mechanisms. Cell 154(1), 26–46 (2013)

Article  Google Scholar 

P. Batista, H. Chang, Long noncoding RNAs: Cellular address Codes in Development and Disease. Cell 152(6), 1298–1307 (2013)

Article  CAS  PubMed  PubMed Central  Google Scholar 

T.R. Mercer, M.E. Dinger, J.S. Mattick, Long non-coding RNAs: insights into functions. Nat. Rev. Genet 10(3), 155–159 (2009)

Article  CAS  PubMed  Google Scholar 

L. Qu et al., Exosome-transmitted lncARSR promotes Sunitinib Resistance in Renal Cancer by acting as a competing endogenous RNA. Cancer Cell. 29(5), 653–668 (2016)

Article  CAS  PubMed  Google Scholar 

C.C. Sun et al., FOXC1-mediated LINC00301 facilitates tumor progression and triggers an immune-suppressing microenvironment in non-small cell lung cancer by regulating the HIF1α pathway. Genome Med. 12(1), 77 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

E. Lau et al., Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression. Genome Med. 12(1), 72 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

P. Gu et al., A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer. Mol. Cancer 18(1), 109 (2019)

Article  Google Scholar 

P. Gu et al., lncRNA HOXD-AS1 regulates proliferation and chemo-resistance of castration-resistant prostate Cancer via recruiting WDR5. Mol Ther. 25(8), 1959–1973 (2017)

J. Luo et al., LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nat. Commun. 10(1), 2571 (2019)

J. Chen et al., TFAP2C-Activated MALAT1 Modulates the Chemoresistance of Docetaxel-Resistant Lung Adenocarcinoma Cells. Mol. Ther. Nucleic Acids 14, 567–582 (2019)

J. Chen et al., Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells. Oncotarget 7(38), 62474–62489 (2016)

Article  PubMed  PubMed Central  Google Scholar 

P. Huang et al., lncRNA profile study reveals the mRNAs and lncRNAs associated with docetaxel resistance in breast cancer cells. Sci. Rep 8(1), 17970 (2018)

Article  Google Scholar 

R. Zhao et al., Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients. Prostate 77(10), 1107–1117 (2017)

Article  CAS  PubMed  Google Scholar 

D. Liu et al., SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C. Cancer Res 74(19), 5597–5607 (2014)

Article  Google Scholar 

W.R. Polkinghorn et al., Androgen receptor signaling regulates DNA repair in prostate cancers. Cancer Discov 3(11), 1245–1253 (2013)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Asim et al., Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer. Nat. Commun 8(1), 374 (2017)

Article  PubMed  PubMed Central  Google Scholar 

B.D. Cook et al., Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol. Cell. Biol. 22(1), 332-342 (2002)

Y. Wu, M. Fabritius, C. Ip, Chemotherapeutic sensitization by endoplasmic reticulum stress: increasing the efficacy of taxane against prostate cancer. Cancer Biol. Ther 8(2), 146–152 (2009)

Article  Google Scholar 

M. Seman et al., Ecto-ADP-ribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr. Med. Chem 11(7), 857-872 (2004)

PubMed  Google Scholar 

C. Bourgeois et al., Identification of regulatory domains in ADP-ribosyltransferase-1 that determine transferase and NAD glycohydrolase activities. J. Biol. Chem 278(29), 26351–26355 (2003)

Article  Google Scholar 

M. Rouleau et al., PARP inhibition: PARP1 and beyond. Nat. Rev. Cancer 10(4), 293–301 (2010)

Article  Google Scholar 

J. Murai et al., Trapping of PARP1 and PARP2 by clinical PARP inhibitors. Eur. J. Cancer 48(21), 87–87 (2012)

Google Scholar 

C. Bian et al., NADP + is an Endogenous PARP Inhibitor in DNA Damage Response and Tumor Suppression. Nat. Commun. 10(1), 693

Y. Cui et al., Acinar with ductal and mucinous adenocarcinoma of prostate cancer complicated with lung metastasis: a case report and literature review. Ann. Palliat. Med. 10(2), 2366–2370 (2021)

Article  PubMed  Google Scholar 

G.E. Polistina et al., Cavitary lung metastasis as relapse of prostate cancer. Respir Med. Case Rep. 29, 100973 (2020)

CAS  PubMed  Google Scholar 

T. Gutschner, S. Diederichs, The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 9(6), 703–719 (2012)

Article  Google Scholar 

Y. Tang et al., LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis. Mol. Cancer 17(1), 77 (2018)

Article  PubMed  PubMed Central  Google Scholar 

M.C. Tsai et al., Long noncoding RNA as modular scaffold of histone modification complexes. Science 329(5992), 689–693 (2010)

Article  Google Scholar 

J. Jia et al., Long noncoding RNA DANCR promotes invasion of prostate cancer through epigenetically silencing expression of TIMP2/3. Oncotarget 7(25), 37868–37881 (2016)

Article  PubMed  PubMed Central  Google Scholar 

Z. Zhang et al., Regulation of androgen receptor splice variant AR3 by PCGEM1. Oncotarget 7(13), 15481–15491 (2016)

Article  PubMed  PubMed Central  Google Scholar 

K. Takayama et al., Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J 32(12), 1665–1680 (2014)

Google Scholar 

H.Q. Ta et al., Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth. Mol. Cancer 18(1), 113 (2019)

Article  Google Scholar 

C.J. Ryan et al., Androgen Decline and Survival During Docetaxel Therapy in Metastatic Castration Resistant Prostate cancer (mCRPC). Prostate Cancer and Prostatic Dis. 23(1), 66-73 (2020)

E. Fouquerel, R.W. Sobol, ARTD1 (PARP1) activation and NAD + in DNA repair and cell death. Dna Repair. 23, 27–32 (2014)

Article  CAS  PubMed